Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Yohei Doi et al.|The Lancet Infectious Diseases|2017Cited by 521
Integrated chromosomal and plasmid sequence analyses reveal diverse modes of carbapenemase gene spread among <i>Klebsiella pneumoniae</i>Sophia David, Māra Saule, Victoria Cohen et al.|Proceedings of the National Academy of Sciences|2020Cited by 176
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trialYehuda Carmeli, Surbhi Malhotra‐Kumar, José Miguel Cisneros et al.|The Lancet Infectious Diseases|2024Cited by 98
2893 A. Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3 REVISIT StudyYehuda Carmeli, Joseph W. Chow, Jose-Miguel Cisneros et al.|Open Forum Infectious Diseases|2023Cited by 25
Blood Culture Sampling Practices among Internal Medicine InpatientsN. Deborah Friedman, Yehuda Carmeli|Clinical Microbiology and Infectious Diseases|2017Cited by 10